Creatinine calibration by clinical laboratories is important because variability among assays adversely affects the accuracy of glomerular filtration rate (GFR) estimation. We describe the calibration of creatinine assays used in the National Kidney Foundation Kidney Early Evaluation Program (KEEP).
K
idney function is assessed best by means of level of glomerular filtration rate (GFR). GFR is difficult to measure directly and therefore usually is estimated from serum levels of endogenous markers. Serum creatinine is the most common measure used to estimate level of kidney function; however, serum level is affected by factors other than GFR, including tubular secretion, generation, and extrarenal elimination. Variation in creatinine generation by age and race are well documented, largely caused by differences in muscle mass and diet. Estimating equations can overcome some of this variation by incorporating age, race, and sex into the creatinine-based assessment. Estimated GFR (eGFR) has become widely adopted in research studies and clinical practice. The most commonly used equations to estimate GFR are the Modification of Diet in Renal Disease (MDRD) Study and CockcroftGault equations. [1] [2] [3] It now is well recognized that use of creatinine assays different from the assay used in the clinical laboratory at which the equation was developed can substantially affect eGFR accuracy.
Variability among laboratories in serum creatinine assays is well known, 4, 5 and calibration therefore is important for optimal results.
The Kidney Early Evaluation Program (KEEP) is a free community-based health-screening program sponsored by the National Kidney Foundation with the help of local National Kidney Foundation affiliates and volunteers. KEEP is designed to raise awareness about chronic kidney disease and prevent its complications by providing testing and information. This report describes KEEP methods of serum creatinine assay calibration to creatinine reference stan-dards at the MDRD Study laboratory at the Cleveland Clinic Research Laboratory (CCRL) and aims to assess the impact of this calibration on the range of GFR estimates. 
METHODS

Calibration
Laboratory Settings
Serum Creatinine Assays at the CCRL
Calibration was established by comparing creatinine values measured at these laboratories with values measured at the CCRL. The CCRL used the modified kinetic rate Jaffé reaction (Beckman Synchron CX3; GMI, Inc., Ramsey, MN) method during the MDRD Study. The Beckman CX3 and Roche enzymatic method (Roche-Hitachi P-Module instrument with Roche Creatininase Plus assay; Hoffman-La Roche, Ltd., Basel, Switzerland) currently are used there. The Roche enzymatic assay at CCRL was shown to be equivalent to creatinine reference standard methods traceable to materials with values assigned by means of isotope dilution mass spectrometry. The Beckman Synchron CX3 assay also was calibrated to these creatinine reference standard methods, and the MDRD Study equation was reexpressed for use with standardized values. Details of the methods and results were described previously. 6, 7 Therefore, calibration for KEEP specimens was performed on the Roche enzymatic assay, and calibration results are expressed as isotope dilution mass spectrometry-standardized values. The Roche assay showed coefficients of variation of 1.1% and 1.6% at creatinine values of 3.84 and 1.00 mg/dL (339 and 88.4 mol/L) in 2005 (n ϭ 409), respectively.
Calibration of Serum Creatinine Assays
SLS and CLS were surveyed for the instrument and assay used for creatinine measurement. A random sample of 200 specimens from each laboratory was requested for assay on the Roche enzymatic at CCRL. A sample size of 200 was Aeroset c8000 creatinine assay, alkaline picrate 
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requested to allow for an SE for the difference between the original and new measurements of less than 0.02 mg/dL (1.8 mol/L).
GFR Estimation
GFR was estimated by using the equation: GFR ϭ 186 ϫ original serum creatinine 
Statistical Analyses
Linear regression was used to assess the significance of the intercept and slope. Slopes and intercepts were adjusted to account for measurement error and regression to the mean by using Deming regression. 8, 9 The presence of outliers was determined initially by visual inspection and, if present, defined as 3 SDs of the absolute percentage of difference. Calibrated creatinine measurements were calculated at values of 1.0 mg/dL (88 mol/L) and 3.0 mg/dL (264 mol/L).
Analyses were carried out using SAS software (version 9.1; SAS Institute, Cary, NC). Figures and Deming regressions were calculated in Excel Analyse-it (version X; Microsoft Corp, Redmond, WA).
8,9
RESULTS
Creatinine Calibration
Both SLS and CLS used the kinetic alkaline picrate methods (Table 1) .
A total of 200 SLS samples from 7 KEEP programs in 7 cities in 3 states was sent to CCRL in October 2005. Of these, 191 were available for analysis. Table 2 and Fig 1 show the distribution of results from comparison of creatinine measurements at both sites. The mean difference was Ϫ0.05 Ϯ 0.08 (SD) mg/dL (Ϫ4 Ϯ 7 mol/L).
Seven outliers were removed from the analysis, leaving 184 samples for calibration. Table 2 and Fig 1 show results of the comparison after exclusion of outliers. Table 3 lists results of the CCRL regression on SLS values before and after exclusion of outliers for both linear and Deming regression. The final CCRL Deming regression showed a slope of 1.003 (95% confidence interval [CI], 0.99 to 1.02; P Ͻ 0.001) and intercept of Ϫ0.04 (95% CI, Ϫ0.59 to Ϫ0.02; P ϭ 0.003) with R 2 ϭ 0.9853. Given the small slope, the final calibration factor consists of only an intercept adjustment.
A total of 226 CLS samples from 7 KEEP programs in 7 cities in 3 states was sent to CCRL in October 2005. Table 2 and Fig 2 show the distribution of results from the comparison of creatinine measurements at both sites. The mean difference was 0.12 Ϯ 0.06 (SD) mg/dL (11 Ϯ 5 mol/L). Twenty-seven outliers were removed from the analysis, leaving 199 samples for calibration. Table 2 and Fig 2 show results of the comparison of creatinine values after exclusion of outliers. Table 3 lists results of the regression of the CCRL on CLS values before and after exclusion of outliers for both linear and Deming regression. Final Deming regression showed a slope of 1.08 (95% CI, 1.07 to 1.09; P Ͻ 0.001) and intercept of Ϫ0.18 (95% CI, Ϫ0.19 to Ϫ0.17; P Ͻ 0.001) with R 2 ϭ 0.9939.
GFR Estimation
The creatinine assay at the SLS was close to the CCRL assay; thus, the effect on eGFR using 
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calibrated versus noncalibrated serum creatinine values was minimal (Fig 3A) . 
DISCUSSION
We describe methods and results of calibration of the serum creatinine assay at the 2 laboratories used by KEEP. The key findings showed variation between laboratories in their comparison to creatinine reference standards and in the impact on eGFR.
For the SLS, creatinine instrument performance was similar to the Roche enzymatic assay at the CCRL, whereas results from the CLS laboratory showed substantial positive bias. This is consistent with the known heterogeneity of creatinine assays currently in use in the United States. A recent survey of the College of the American Pathologists (CAP) of 5,624 participating clinical laboratories in the United States Note: To convert serum creatinine in mg/dL to mol/L, multiply by 88.4. *Slope was 1.003 Ϯ 0.009 (SE) and therefore considered to be small relative to the imprecision in the assay and dropped. showed that mean bias varied from Ϫ0.06 to ϩ0.31 mg/dL (Ϫ5 to ϩ27 mol/L) in 50 instrument-method peer groups. Bias variability was related to instrument manufacturer, rather than method type; 24 of 38 alkaline picric acid methods (63%) and 6 of 12 enzymatic methods (50%) showed significant biases.
10 Of interest, instruments and assays analogous to those used by SLS and CLS were found to have a pattern in magnitude of bias similar to the present study. The bias of the Olympus 400-640 (Olympus America, Inc., Center Valley, PA) using the kinetic alkaline picrate method in the CAP survey was 0.09 mg/dL (8 mol/L), whereas in the present study, bias of a similar machine at the SLS was 0.04 mg/dL (4 mol/L). Similarly, bias of the Abbott Aeroset (Abbott Laboratories, Abbott Park, IL) using the kinetic picrate method in the CAP study was 0.14 mg/dL (12 mol/L), and bias using a similar machine at the CLS laboratory was 0.1 mg/dL (9 mol/L).
The impact of calibration on the accuracy of the GFR estimating equation is now well recognized. 4, 5, 11 Errors are larger at higher levels of GFR and although are smaller near 60 mL/min/ 1.73 m 2 (1.0 mL/s1.73 m 2 ), they can still cause substantial differences in estimated prevalence of CKD when applied to large populations. [12] [13] [14] Because of the large variation among laboratories and instruments in calibration of creatinine instruments, anticipating the difference between one machine and the next is difficult. It is not Limitations of this analysis include our use of samples from only 1 month to test each laboratory. This may be a particular problem for SLS, where KEEP measured creatinine for 5 years before calibration. However, laboratories generally are skilled at reducing drift over time, and the same instrument was in use during the 5 years. New creatinine instruments or assays used in the CLS laboratory should be tested going forward to maintain current standards.
In summary, calibration of the serum creatinine assay in KEEP has a larger effect in the laboratory currently in use than in the laboratory formerly used. Calibration improves the accuracy of estimating CKD prevalence in the overall program and detection of CKD in individual participants.
